BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28376765)

  • 1. The germline variants in DNA repair genes in pediatric medulloblastoma: a challenge for current therapeutic strategies.
    Trubicka J; Żemojtel T; Hecht J; Falana K; Piekutowska-Abramczuk D; Płoski R; Perek-Polnik M; Drogosiewicz M; Grajkowska W; Ciara E; Moszczyńska E; Dembowska-Bagińska B; Perek D; Chrzanowska KH; Krajewska-Walasek M; Łastowska M
    BMC Cancer; 2017 Apr; 17(1):239. PubMed ID: 28376765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline variants in MRE11/RAD50/NBN complex genes in childhood leukemia.
    Mosor M; Ziółkowska-Suchanek I; Nowicka K; Dzikiewicz-Krawczyk A; Januszkiewicz-Lewandowska D; Nowak J
    BMC Cancer; 2013 Oct; 13():457. PubMed ID: 24093751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.
    Carlo MI; Ravichandran V; Srinavasan P; Bandlamudi C; Kemel Y; Ceyhan-Birsoy O; Mukherjee S; Mandelker D; Chaim J; Knezevic A; Rana S; Fnu Z; Breen K; Arnold AG; Khurram A; Tkachuk K; Cipolla CK; Regazzi A; Hakimi AA; Al-Ahmadie H; Dalbagni G; Cadoo KA; Walsh MF; Teo MY; Funt SA; Coleman JA; Bochner BH; Iyer G; Solit DB; Stadler ZK; Zhang L; Rosenberg JE; Taylor BS; Robson ME; Berger MF; Vijai J; Bajorin DF; Offit K
    J Clin Oncol; 2020 Feb; 38(5):406-414. PubMed ID: 31794323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
    Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS
    JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygous germ-line mutations in the NBN gene predispose to medulloblastoma in pediatric patients.
    Ciara E; Piekutowska-Abramczuk D; Popowska E; Grajkowska W; Barszcz S; Perek D; Dembowska-Bagińska B; Perek-Polnik M; Kowalewska E; Czajńska A; Syczewska M; Czornak K; Krajewska-Walasek M; Roszkowski M; Chrzanowska KH
    Acta Neuropathol; 2010 Mar; 119(3):325-34. PubMed ID: 19908051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
    Waszak SM; Northcott PA; Buchhalter I; Robinson GW; Sutter C; Groebner S; Grund KB; Brugières L; Jones DTW; Pajtler KW; Morrissy AS; Kool M; Sturm D; Chavez L; Ernst A; Brabetz S; Hain M; Zichner T; Segura-Wang M; Weischenfeldt J; Rausch T; Mardin BR; Zhou X; Baciu C; Lawerenz C; Chan JA; Varlet P; Guerrini-Rousseau L; Fults DW; Grajkowska W; Hauser P; Jabado N; Ra YS; Zitterbart K; Shringarpure SS; De La Vega FM; Bustamante CD; Ng HK; Perry A; MacDonald TJ; Hernáiz Driever P; Bendel AE; Bowers DC; McCowage G; Chintagumpala MM; Cohn R; Hassall T; Fleischhack G; Eggen T; Wesenberg F; Feychting M; Lannering B; Schüz J; Johansen C; Andersen TV; Röösli M; Kuehni CE; Grotzer M; Kjaerheim K; Monoranu CM; Archer TC; Duke E; Pomeroy SL; Shelagh R; Frank S; Sumerauer D; Scheurlen W; Ryzhova MV; Milde T; Kratz CP; Samuel D; Zhang J; Solomon DA; Marra M; Eils R; Bartram CR; von Hoff K; Rutkowski S; Ramaswamy V; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Malkin D; Gajjar A; Korbel JO; Pfister SM
    Lancet Oncol; 2018 Jun; 19(6):785-798. PubMed ID: 29753700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
    Vargas-Parra GM; González-Acosta M; Thompson BA; Gómez C; Fernández A; Dámaso E; Pons T; Morak M; Del Valle J; Iglesias S; Velasco À; Solanes A; Sanjuan X; Padilla N; de la Cruz X; Valencia A; Holinski-Feder E; Brunet J; Feliubadaló L; Lázaro C; Navarro M; Pineda M; Capellá G
    Int J Cancer; 2017 Oct; 141(7):1365-1380. PubMed ID: 28577310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the NBN gene mutation I171V a potential risk factor for malignant solid tumors in children?
    Nowak J; Mosor M; Nowicka K; Rembowska J; Januszkiewicz D
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):e248-9. PubMed ID: 21436738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.
    Berginc G; Bracko M; Ravnik-Glavac M; Glavac D
    Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients.
    Mangoni M; Bisanzi S; Carozzi F; Sani C; Biti G; Livi L; Barletta E; Costantini AS; Gorini G
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):52-8. PubMed ID: 20708344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncommon nucleotide excision repair phenotypes revealed by targeted high-throughput sequencing.
    Calmels N; Greff G; Obringer C; Kempf N; Gasnier C; Tarabeux J; Miguet M; Baujat G; Bessis D; Bretones P; Cavau A; Digeon B; Doco-Fenzy M; Doray B; Feillet F; Gardeazabal J; Gener B; Julia S; Llano-Rivas I; Mazur A; Michot C; Renaldo-Robin F; Rossi M; Sabouraud P; Keren B; Depienne C; Muller J; Mandel JL; Laugel V
    Orphanet J Rare Dis; 2016 Mar; 11():26. PubMed ID: 27004399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma.
    Nogueira GA; Lourenço GJ; Oliveira CB; Marson FA; Lopes-Aguiar L; Costa EF; Lima TR; Liutti VT; Leal F; Santos VC; Rinck-Junior JA; Lima CS
    Int J Cancer; 2015 Aug; 137(4):810-8. PubMed ID: 25598504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic challenges in a child with early onset desmoplastic medulloblastoma and homozygous variants in MSH2 and MSH6.
    Taeubner J; Wimmer K; Muleris M; Lascols O; Colas C; Fauth C; Brozou T; Felsberg J; Riemer J; Gombert M; Ginzel S; Hoell JI; Borkhardt A; Kuhlen M
    Eur J Hum Genet; 2018 Mar; 26(3):440-444. PubMed ID: 29302048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique DNA repair gene variations and potential associations with the primary antibody deficiency syndromes IgAD and CVID.
    Offer SM; Pan-Hammarström Q; Hammarström L; Harris RS
    PLoS One; 2010 Aug; 5(8):e12260. PubMed ID: 20805886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of ambiguous mutations in DNA mismatch repair genes identified in a population-based study of colorectal cancer.
    Barnetson RA; Cartwright N; van Vliet A; Haq N; Drew K; Farrington S; Williams N; Warner J; Campbell H; Porteous ME; Dunlop MG
    Hum Mutat; 2008 Mar; 29(3):367-74. PubMed ID: 18033691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BLM-DNA2-RPA-MRN and EXO1-BLM-RPA-MRN constitute two DNA end resection machineries for human DNA break repair.
    Nimonkar AV; Genschel J; Kinoshita E; Polaczek P; Campbell JL; Wyman C; Modrich P; Kowalczykowski SC
    Genes Dev; 2011 Feb; 25(4):350-62. PubMed ID: 21325134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploratory analysis of ERCC2 DNA methylation in survival among pediatric medulloblastoma patients.
    Banfield E; Brown AL; Peckham EC; Rednam SP; Murray J; Okcu MF; Mitchell LE; Chintagumpala MM; Lau CC; Scheurer ME; Lupo PJ
    Cancer Epidemiol; 2016 Oct; 44():161-166. PubMed ID: 27607585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations.
    Haraldsdottir S; Hampel H; Tomsic J; Frankel WL; Pearlman R; de la Chapelle A; Pritchard CC
    Gastroenterology; 2014 Dec; 147(6):1308-1316.e1. PubMed ID: 25194673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene.
    Bartkova J; Tommiska J; Oplustilova L; Aaltonen K; Tamminen A; Heikkinen T; Mistrik M; Aittomäki K; Blomqvist C; Heikkilä P; Lukas J; Nevanlinna H; Bartek J
    Mol Oncol; 2008 Dec; 2(4):296-316. PubMed ID: 19383352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.